id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-D-0072-0005,FDA,FDA-2005-D-0072,"Guidance for Public, FDA Advisory Committee Members, and FDA Staff; Availability: The Open Public Hearing at FDA Advisory Committee Meetings;Availability",Notice,NAD-Notice of Availability of Data,2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2024-11-07T22:28:26Z,2010-31022,1,0,0900006480bb387e
FDA-2005-D-0072-0006,FDA,FDA-2005-D-0072,"Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: The Open Public Hearing at FDA Advisory Committee Meeting; Final Guidance",Other,GDL-Guidance (Supporting and Related Materials),2010-12-10T05:00:00Z,2010,12,2010-12-10T05:00:00Z,,2010-12-11T00:41:54Z,,0,0,0900006480bb3e0d
FDA-2005-D-0072-0001,FDA,FDA-2005-D-0072,Draft Guidance on the Open Public Hearing; Food and Drug Administration Advisory Committee Meetings; Availability,Notice,NAD-Notice of Availability of Data,2005-02-15T05:00:00Z,2005,2,2005-02-14T05:00:00Z,2005-06-16T03:59:59Z,2009-06-03T20:14:04Z,,0,0,090000648043f30a
FDA-2005-D-0072-0002,FDA,FDA-2005-D-0072,Guidance on the Open Public Hearing; Food and Drug Administration Advisory Committee Meetings; Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2005-02-15T05:00:00Z,2005,2,,,2024-11-12T04:12:35Z,,1,0,090000648043f30b